ABEONA THERAPEUTICS INC. — Form SCHEDULE 13D
Filed October 23, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 28/100
What the filing says
James Russell (via his revocable trust) purchased 56,755 shares of Abeona Therapeutics common stock between August 17 and October 15, 2026, at prices ranging from $4.35 to $6.10 per share, totaling approximately $281,000. The purchases accelerated notably in early October, coinciding with a sharp stock price decline from ~$6 to ~$4.35. This signals insider confidence but at depressed valuations.
Why this rating
Modest absolute accumulation (~$281K) is <0.11% of company market cap ($273M). Insider buying is constructive but routine; no disclosed stake threshold or control intent material here.
See more from October 23, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.